Recce Pharmaceuticals Ltd. has released a press release.
HREC Approves Comparator Study for Pivotal Phase 3 DFI
Earlier from Recce Pharmaceuticals
- Vietnamese Patent Granted for RECCE Anti-Infectives
- AUD $3.7M Income Tax Refund Received
- Placement & SPP to raise $8 million
- HREC Approval Accelerates Global Phase 3 DFI Strategy